Global Diabetic Neuropathic Pain API Manufacturers, Marketed and Phase III Drugs Landscape 2017-2018 - Research and Markets
February 17 2017 - 11:41AM
Business Wire
Research and Markets has announced the addition of the "Diabetic
Neuropathic Pain - Global API Manufacturers, Marketed and Phase III
Drugs Landscape, 2017" drug pipelines to their offering.
Diabetic Neuropathic Pain - Global API Manufacturers, Marketed
and Phase III Drugs Landscape, 2017, provides comprehensive
insights about the marketed drugs, drug sales, Phase III pipeline
drugs and their API Manufacturers across the globe.
A key objective of the Diabetic Neuropathic Pain Report is to
understand the market and pipeline status of the drugs around the
Diabetic Neuropathic Pain to explore the generic development
opportunities, licensing opportunities and to gain competitive
advantage on designing pipeline strategies. The Report provides the
historical and forecasted sales of the drugs till 2018.
The Diabetic Neuropathic Pain Report gives insights into patents
providing the patent protection data and marketing exclusivity of
all the drugs across the Diabetic Neuropathic Pain.
While the leading brands, companies and chemicals are considered
thoroughly, the report also provides details on the Global API
Manufacturers across the globe covering Drug Master Filings of US,
Europe and API Manufacturers in Asia specifically China and
India.
Key Topics Covered:
1. Indication Overview
2. Market Drugs Landscape
3. Global API Manufacturers Assessment
4. Phase III Drugs Landscape
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Diabetic Neuropathic Pain
7. Phase III Drugs for Diabetic Neuropathic Pain
8. Discontinued Drugs for Diabetic Neuropathic Pain
9. Appendix
For more information about this drug pipelines report visit
http://www.researchandmarkets.com/research/dhslzl/diabetic
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170217005545/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Related Topics: Central Nervous System Drugs
, Analgesics, Endocrine and Metabolic Disorders Drugs